Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Assets Average (2019 - 2025)

Historic Assets Average for Bicycle Therapeutics (BCYC) over the last 7 years, with Q3 2025 value amounting to $798.1 million.

  • Bicycle Therapeutics' Assets Average fell 2229.51% to $798.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $798.1 million, marking a year-over-year decrease of 2229.51%. This contributed to the annual value of $776.1 million for FY2024, which is 5430.26% up from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' Assets Average is $798.1 million, which was down 2229.51% from $858.0 million recorded in Q2 2025.
  • Bicycle Therapeutics' Assets Average's 5-year high stood at $1.0 billion during Q3 2024, with a 5-year trough of $192.5 million in Q1 2021.
  • Its 5-year average for Assets Average is $568.3 million, with a median of $469.7 million in 2022.
  • As far as peak fluctuations go, Bicycle Therapeutics' Assets Average skyrocketed by 14399.21% in 2022, and later crashed by 2229.51% in 2025.
  • Bicycle Therapeutics' Assets Average (Quarter) stood at $380.6 million in 2021, then rose by 8.75% to $413.9 million in 2022, then soared by 49.08% to $617.0 million in 2023, then skyrocketed by 58.31% to $976.8 million in 2024, then dropped by 18.3% to $798.1 million in 2025.
  • Its Assets Average stands at $798.1 million for Q3 2025, versus $858.0 million for Q2 2025 and $920.4 million for Q1 2025.